Envy Medical Introduces Lumixyl Brightening System

Envy Medical, Inc., recently introduced its new Lumixyl Brightening System, a multi-faceted approach to treat hyperpigmentation without irritation or other side effects associated with prescription hydroquinone or retinoids. This professional skincare system introduction builds on the success of the Lumixyl Topical Brightening Crème introduced in 2009. “The Lumixyl Topical Brightening System is an entirely new approach to naturally brighter, more vibrant skin, representing a new physician-grade standard in skincare,” explained Basil Hantash, MD, PhD, a board certified Stanford-trained dermatologist and vice-chairman of the board at Envy Medical, who also helped develop the Lumixyl peptide technology. According to the company, the four products in the Lumixyl Brightening System work synergistically to target existing hyperpigmentation and to prevent its recurrence. For most patients these formulations can eliminate the need to use hydroquinone or its bi-products, which are controversial due to their potential side effects. Lumixyl products are proven to be powerful but gentle on skin. “Physicians and the public at large have been calling for a viable alternative to prescription hydroquinone therapies,” commented Envy Medical CEO, Curtis A. Cluff, in a press release. “We are very pleased to be able to answer that call with a system that provides visible brightening with a safe and non-irritating formula.”